Latest News About - single use devices
Tools
Friday, September 24, 2021
2:18:00 PM CEST
Language Selection
For any category/filter, users can choose:
- the language of the categorized news items (e.g. fr and de to display only those news items in French and German)
- the language of the user interface (e.g. it for Italian)
In Top Stories, the user can display the largest clusters of news items for one language only (e.g. en shows all clusters in English)
Country Selection
Users can choose:
- country mentioned in the news item (articles about a country)
- country in which the news item was published (articles from a country)
Languages 
Select your languages
Interface:
Extracted quotes
Sean Miller said: "Our partnership with 3D Systems is one of the most exciting elements about this project," 
markets-businessinsider Thursday, September 23, 2021 10:35:00 PM CEST
Sean Miller said: "Our partnership with 3D Systems is one of the most exciting elements about this project,"
prnewswire Thursday, September 23, 2021 10:20:00 PM CEST
Gary Warren said: "At ivWatch, we are on a global mission to provide hospitals around the world with coveted, proven technology that will add value to the patient safety movement, and also minimize adverse events in IV therapy,"
prnewswire Wednesday, September 22, 2021 2:38:00 PM CEST
Phil Roy said: "We are thrilled to expand our surgical energy product portfolio with best-in-class advanced bipolar energy solutions that were designed with surgeons' needs and clinical outcomes as the primary drivers,"
antaranews-en Wednesday, September 22, 2021 10:11:00 AM CEST
Phil Roy said: "We are thrilled to expand our surgical energy product portfolio with best-in-class advanced bipolar energy solutions that were designed with surgeons' needs and clinical outcomes as the primary drivers,"
4-traders Tuesday, September 21, 2021 6:09:00 AM CEST
Thomas Burns said: “This licensing agreement adds a promising therapeutic class that expands the focus of our emerging Corneal Health franchise into new and globally underserved disease indications,”
businesswire Monday, September 20, 2021 6:36:00 PM CEST
Mark Foster said: "There is incredible potential in this company. Not only does the technology of Xenoscope advance the bar for laparoscopic surgery, but it also makes minimally invasive surgery more accessible. Which is good for everyone. I see every reason for the successful introduction of the Xenocope into the US market and other markets around the world,"
markets-businessinsider Monday, September 20, 2021 2:55:00 PM CEST
Mark Foster said: "There is incredible potential in this company. Not only does the technology of Xenoscope advance the bar for laparoscopic surgery, but it also makes minimally invasive surgery more accessible. Which is good for everyone. I see every reason for the successful introduction of the Xenocope into the US market and other markets around the world,"
prnewswire Monday, September 20, 2021 2:20:00 PM CEST
Thomas Burns said: “This licensing agreement adds a promising therapeutic class that expands the focus of our emerging Corneal Health franchise into new and globally underserved disease indications,”
4-traders Monday, September 20, 2021 1:09:00 PM CEST
Scott Thielman said: “Mandy is leading research at the cutting edge of personalized cancer care. It’s gratifying to discover that our device development skills can benefit her work,” “Our designers and engineers were highly motivated to support this project”
mddionline Friday, September 17, 2021 2:16:00 AM CEST
Scott Thielman explained: “The genome may be our biological blueprint, but the proteome is what actually gets built as proteins and is expressed under real-world conditions,” “Analyze the spectrum of proteins in a tumor cell and you have a quantitative basis for diagnosis and therapy”
mddionline Friday, September 17, 2021 2:16:00 AM CEST
Claudio Galbiati continua: “Non vorremmo trovarci nuovamente impreparati ad una nuova emergenza come accaduto nella Fase 1 del Covid-19 – (\*) – anche perché abbiamo ora la possibilità di organizzare scorte e approvvigionamenti di DPI per garantire una continuità sia alle strutture sanitarie che alle stesse imprese. Non possiamo perdere questa occasione né vanificare gli sforzi fatti in questo periodo”
insic Wednesday, September 15, 2021 3:12:00 PM CEST
Marco Marchetti continua: “Quello che ci spaventa è la previsione della lenta ripresa del principale volano di crescita per il nostro Paese che è il turismo – (\*) – Molte sono le richieste già pervenute al governo dai colleghi dell’industria del turismo che condivido in pieno. Anzi, come Associazione abbiamo interessato diversi ministeri (il Mef, Il Mibact, il Mise) affinché il turismo venga considerato nella sua completa filiera, incluso il nostro settore delle lavanderie industriali che forniscono tutta la biancheria e il relativo trattamento di sanificazione per gli hotel e ristoranti”
insic Wednesday, September 15, 2021 3:12:00 PM CEST
Claudio Galbiati dichiara: “Come sezione Safety di Assosistema Confindustria abbiamo proposto all’Istituto Superiore della Sanità un processo di riutilizzo concordato tra i produttori per riutilizzare i filtri P2 e P3 usati con le semimaschere e, ove possibile, facciali filtranti FFP2 e FFP3 in modo tale da avere maggiore disponibilità di prodotti sul mercato”
insic Wednesday, September 15, 2021 3:12:00 PM CEST
Claudio Galbiati aggiunge: “Onde evitare il perdurare di confusione e di inutili polemiche che alla fine possono risultare anche dannose per gli utilizzatori – (\*) – è doveroso distinguere i DPI dalle mascherine chirurgiche. Queste ultime sono dispositivi medici e nascono con lo scopo di proteggere il paziente in situazioni specifiche (es: sala operatoria) e non il personale sanitario, dal momento che non presentano un bordo di tenuta sul volto ed uno specifico sistema filtrante per aerosol solidi e liquidi, a differenza dei DPI. L’OMS è stata molto chiara al riguardo: i DPI devono essere destinati al personale sanitario a contatto con la malattia e le mascherine chirurgiche per diminuire il contagio verso l’esterno”
insic Wednesday, September 15, 2021 3:12:00 PM CEST
Thomas Burns said: “Since our founding in 1998, Glaukos has invested considerable time and resources to develop novel technologies that have pioneered an entirely new treatment category for glaucoma surgeons and their patients,”
4-traders Wednesday, September 15, 2021 1:10:00 PM CEST
Most associated names
Daily number of articles in this category
Trend data not available for this selection.
Contact: 